Purpose Chronic inflammation has been hypothesized to play a significant role in the aetiology of cancer, including gastric cancer. In the present study, we sought to examine pre-diagnostic systemic cytokine levels in plasma, which can be seen as markers of aggregate inflammation, and risk of distal gastric cancer in a case-control study nested within the prospective Shanghai Men's Health Study. Methods Circulating levels of eight inflammation-related cytokines were measured in the plasma collected at baseline for 180 incident cases of distal gastric cancer and 358 matched controls. Helicobacter pylori sero-positivity was assessed using multiplex serology. Conditional logistic regression was used to calculate odds ratios (ORs) and 95 % confidence intervals (CI).
Introduction
The strong association between cancer and inflammation has long been observed, and currently it is believed that many if not most cancers arise in an inflammatory environment. Inflammation both provides a fertile, pro-growth background for cancer to develop and aids in cancer progression [1] . As the leading cause of gastric cancer, infection with Helicobacter pylori and in its interaction with the host immune response causes inflammation, and the resulting degree of inflammation is related to the risk of the development of cancer [2] . Additionally, many epidemiologic studies have shown that regular use of non-steroidal anti-inflammatory drugs reduce the risk of gastric cancer [3] [4] [5] .
To investigate chronic inflammation in the host, a number of recent studies have examined inflammatory cytokine polymorphisms and gastric cancer risk, with many focusing on interleukin-1 beta gene promoter polymorphisms, with inconsistent findings [6, 7] . Other genes that encode proteins related to inflammation and H. pylori, including IL-8, IL-10, and tumour necrosis factor-a, have been examined as to their association with gastric cancer risk, also with mixed results [6] . Many of the challenges in studying genetic polymorphisms and gastric cancer risk are similar to those in any gene association study, such as multiple comparisons, phenotype heterogeneity, locus heterogeneity, population stratification, and variation in allele frequency among populations [6] .
In the present study, we sought to examine pre-diagnostic systemic cytokine levels in plasma, which can be seen as markers of aggregate inflammation and risk of distal gastric cancer in a prospective cohort study in China.
Materials and methods

Study population
From 2002 to 2006, the Shanghai Men's Health Study (SMHS) recruited 61,582 men, aged 40-74 years and without a history of cancer, who were permanently residing in urban Shanghai. A structured, in-person interview was conducted by trained former medical professionals to collect information on demographic factors, medical history, family cancer history, usual diet, and other lifestyle factors [8, 9] . Following an established protocol [10] , a 10-ml blood sample was drawn from each participant. Samples were then transported by insulated portable boxes with ice packs and were processed within 6 h for long-term storage at -80°C. Plasma samples were used for inflammatory cytokines and H. pylori assays. Approximately 75 % of SMHS participants provided blood samples at baseline.
Case identification
Linkage with the Shanghai Cancer Registry and the Shanghai Vital Statistics Unit allowed for ascertainment of incident gastric cancer cases in the SMHS. All possible links were confirmed by home visits, and cancer diagnoses were further confirmed through medical chart review from notifying hospitals. Between 2002 and 2009, 255 gastric cancer cases were identified among SMHS participants who donated a blood sample at baseline and who were not diagnosed with cancer within one month of blood sample collection. The 29 (11.4 
Control selection
For each case, two controls were chosen matched on age (±2 years), date (±30 days), and time (morning or afternoon) of sample collection; time interval since last meal (±2 h); and use of antibiotics in the previous week. These matching factors were selected due to the a priori belief that details relevant to blood collection can affect the sensitivity and specificity of many biological assays. After excluding a sample with heavy haemolysis which failed the cytokine assay, this study included 180 cases of distal gastric cancer and 358 matched controls. Analyzer following the manufacturer's protocols. A standard curve was run for each assay batch and two controls (higher and lower) were run for each of the seven plates (for a total of 14 quality control samples). The samples from the same case-control set were analysed in the same plate. All the samples were tested in duplicate. The interassay coefficients of variation were 7-14 %.
Helicobacter pylori multiplex serology As previously described [11, 12] , H. pylori multiplex serology, based on a glutathione S-transferase capture immunosorbent assay combined with fluorescent bead technology [13, 14] , was used to determine sero-status of antibodies to fifteen H. pylori specific antigens (UreA, Catalase, GroEL, NapA, CagA, CagM, Cagd, HP0231, VacA, HpaA, Cad, HyuA, Omp, HcpC, HP0305). For each of these antigens, specific cut-point values were created based on 46 H. pylori sero-negative sera from a previous study [15] and run within this assay. Individuals were classified as H. pylori sero-positive if they had sero-positive results to C4 H. pylori proteins examined. This definition of H. pylori sero-positivity was found to have excellent agreement (j = 0.70) with commercial serological assay classification [11] .
Statistical analysis
The individual associations of circulating levels of each cytokine and distal gastric cancer risk were assessed using conditional logistic regression to obtain odds ratios (ORs) and 95 % confidence intervals (CIs). Levels of each of the cytokines analysed were categorized in quartiles based on the distribution in the controls, and the second through fourth quartiles were included in the models as indicator variables (with the lowest quartile serving as the reference group). To test for a linear trend across quartiles of each cytokine, an ordinal variable was created and assigned the quartile rank (1-4) for each individual cytokine. Baseline characteristics that were a priori considered to be associated with both cytokine levels and gastric cancer were considered for inclusion in the adjusted models. The final adjusted models included those characteristics that were associated with both the exposure and the outcome in the data, specifically: history of gastritis (yes/no); regular aspirin use (yes/no); smoking status (current/not current); and number of sero-positive results to 6 H. pylori virulence proteins (Omp, HP0305, HyuA, HpaA, CagA, and VacA).
To determine whether infection with H. pylori magnifies the effect of circulating cytokine levels on gastric cancer risk, analyses were performed among high-risk subgroups of the study population. Specifically, separate models were run among only those individuals who were H. pylori seropositive and both H. pylori sero-positive and CagA seropositive. To test for effect modification by H. pylori status, a likelihood ratio test was used for the product of the cytokine as a linear trend by category and the dichotomous categorization of H. pylori status, as measured in the two ways above.
To minimize the possibility of reverse causation, whereby undiagnosed subclinical or pre-malignant lesions are inflating cytokine levels, we performed a time lag analysis, by running separate models on the study population by time between baseline blood draw and diagnosis.
All statistical analyses were performed using SAS 9.2 (SAS Institute, Cary, NC).
Results
Differences in baseline characteristics between distal gastric cancer cases and their matched controls are shown in Table 1 . The vast majority of all participants tested seropositive for H. pylori, including both cases and controls (98 vs. 95 %, respectively; p = 0.10). Cases were more likely to be current smokers, to have had a diagnosis of chronic gastritis, to have a lower average fruit intake, and to not be regular users of aspirin. For all cytokines examined, cases had higher median levels than controls, but only for IL-8 was there a significant difference in the distribution of scores by case-control status, assessed by the Wilcoxon rank sum test (p = 0.03).
In fully adjusted regression models, individuals classified in the top quartiles of all of the eight cytokines examined had a suggested increase in risk of gastric cancer compared to individuals in the lowest quartile of these cytokines, although only for the cytokine IL-8 did these odds ratios reach statistical significance at the p \ 0.05 level (ORs of 1.91, 2.10, and 2.30, respectively) ( Table 2) .
While the majority of our study population was not only sero-positive for H. pylori, but for the H. pylori virulence protein CagA, we still sought to assess whether H. pylori infection magnifies the effect of high circulating cytokine levels on gastric cancer risk. However, we found no appreciable differences in these higher risk groups as compared to the associations in the entire group. Specifically, among only those individuals sero-positive for CagA-positive H. pylori (94 % of cases and 92 % of controls), the respective ORs were 1.0 (reference), 1.6 (0.9-3.1), 2.1 (1.2-3.9), and 2.1 (1.1-4.0), p for trend of 0.01, for the association of increasing IL-8 levels in quartiles with distal gastric cancer risk.
Limiting the analyses by excluding individuals diagnosed within one, two, three, or four years after blood draw did not change the interpretation of the results from the primary findings. Specifically, for those individuals diagnosed more than four years after recruitment (and their matched controls), individuals in the second, third, and fourth quartiles of IL-8 levels, compared to those in the lowest quartile, continued to have an excess risk of gastric cancer 
Discussion
This prospective study of the association of circulating plasma levels of eight different inflammation-associated cytokines and gastric cancer risk found that increasing levels of IL-8 were associated with increasing risk of distal gastric cancer. Specifically, individuals with IL-8 levels above the lowest quartile were at twofold increased odds of this deadly disease. While almost all risk estimates above the lowest quartile for the other seven cytokines measured (IL-1b, IL-2, IL-4, IL-6, IL-10, TNF-a, and IFN-c) were suggestive of a direct association with gastric cancer risk, no other significant associations were found.
Previously, in a nested case-control study of systemic cytokine levels and gastric cancer risk among Chinese women in Shanghai, we also observed a positive association between gastric cancer risk and plasma IL-8 levels (highest tertile compared to lowest tertile: OR 1.41; 95 % CI 0.85-2.36; p for trend 0.18) [16] , although neither the point estimate nor the trend test was statistically significant, perhaps due to a small sample size (141 cases and 221 controls). In the study conducted among women, we found a direct association between increasing plasma IL-6 levels and gastric cancer risk (highest tertile compared to lowest tertile: OR 1.73; 95 % CI 1.00-3.00; p for trend 0.04). When we analysed the associations of IL-6 and IL-8 and gastric cancer risk among participants in the present study, from the Shanghai Men's Health Study (SMHS), in a manner similar to that done in the Shanghai Women's Health Study (SWHS)-categorizing cytokine levels in tertiles, adjusting for education only, including all gastric cancer cases (such as those coded as overlapping or unspecified, although we were not able to include cardia cancer cases as done in the women's study), and stratifying by time interval between blood collection and diagnosisthe results were similar, although in the SMHS they did not reach statistical significance. Specifically, for the SWHS main finding that individuals in the highest tertile of IL-6 levels had an increased risk of gastric cancer after more than four years of follow-up (OR 2.45; 95 % CI 1.0-6.7; p for trend 0.04), the equivalent analysis in the SMHS resulted in a similar suggestion of increased risk for men in the highest tertile of IL-6 levels (OR 1.87; 95 % CI 0.9-4.1; p for trend 0.14).There are, however, still noticeable differences in the cohorts, as women in Shanghai overall have a significantly lower risk of gastric cancer than men, and very few women smoked cigarettes regularly (5 % are ever smokers).
The few other studies of circulating IL-8 levels and gastric cancer have also found significant associations, including a small Italian cross-sectional study that found higher mean levels of serum IL-8 in gastric cancer cases than in healthy volunteers or in individuals with other diseases (all p \ 0.001) [17] . A larger, Polish case-control study also found significantly higher IL-8 levels in gastric cancer cases than controls (p \ 0.001) [18] . However, the present study is only the second prospective study we are aware of, after the study discussed above in Shanghai women, to explore pre-diagnostic circulating IL-8 levels and gastric cancer risk.
A number of studies have investigated IL-8 polymorphisms and gastric cancer risk, and a recent meta-analysis that included 18 studies found that the AA genotype of the IL-8 -251 promoter polymorphism, located on chromosome 4q12-21, is significantly associated with overall risk of gastric cancer, and among Asian populations, specifically [19] . Interestingly, and consistent with the findings of the present study, the authors of the meta-analysis did not find that this high-risk AA genotype was modified by H. pylori infection.
The use of plasma levels of cytokines in the present study allowed for an estimation of an aggregate measure of multiple genetic variants, reflecting each individual's phenotype, and enhancing the statistical power of the study. At the same time, circulating cytokine levels are also reflective of current inflammation not related to H. pylori or gastric atrophy, such as that arising from colds as well as chronic or acute illnesses. Nonetheless, we do not expect systemic differences in rates of such illnesses at baseline between cases and controls in this prospective study. While examination of plasma cytokines is still relatively new, a recent study examining within-person variation of plasma adipokine levels, including IL-1b, IL-6, Il-8, and TNF-a, found no significant seasonal variation, and intraclass coefficients ranging from reasonably high values (0.77 for IL-1b and 0.73 IL-6) to a bit lower (0.51 for IL-8 and 0.48 for TNF-a) [20] . Systemic cytokine levels have previously been found to be associated with colorectal cancer rates of proliferation and apoptosis [21] , risk of celiac disease [22] , and, most recently, lung cancer risk [23] . Thus, the findings of the present study of the association of increased circulating IL-8 levels with increased gastric cancer risk, independent of H. pylori status, add to our understanding of the disease and further efforts to uncover biomarkers of disease risk.
